-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: Introduction to Homology Models
Author:
InnoModels Biotechnology
Release time:
2024-01-30
InnoModels Biotechnology is committed to promoting cutting-edge research in the field of life sciences and providing high-quality homology modeling services to scientists and research institutions. Homology modeling is an indispensable tool in biomedical research. Through genetic engineering technology, specific genes can be introduced, modified or deleted in model organisms to simulate human diseases and conduct drug testing, providing scientists with unique opportunities to gain in-depth understanding of biology, disease mechanisms and drug effects.
1. Overview of InnoModels Biotechnology
InnoModels Biotechnology is a company focusing on genetically engineered homology modeling, upholding the philosophy of efficiency, professionalism, and innovation to provide excellent services to research institutes and scientists in the field of life sciences around the world. The company is committed to utilizing the most advanced gene editing technology to provide tailor-made homology models to meet the needs of different research fields.
2. Application areas of homology models
Homology models of InnoModels Biotechnology have been widely used in several research fields. From cancer research to neuroscience, genetics and drug development, homology models provide a powerful toolbox for researchers. By introducing human genes or simulating functional variations of specific genes in model organisms, researchers are able to better understand the pathogenesis of diseases, screen potential drug targets, and accelerate the process of new drug development.

3. Advanced Gene Editing Technology
InnoModels Biotechnology uses the most advanced gene editing technologies, including CRISPR/Cas9, to ensure efficient and precise editing of genes. These technologies not only improve the efficiency of creating homologous models, but also enable researchers to perform more complex genetic manipulations to better mimic the complexity of human diseases.
4. Diverse selection of animal models
The Company offers a diverse selection of animal models, including mice. These models have their own advantages and can meet different research areas and experimental needs. Customers can choose the most suitable model according to their specific research purposes, so as to better carry out experimental research.
5. Professional technical support and service
InnoModels Biotechnology not only provides high-quality homology models, but also provides professional technical support and service for customers. The company's scientific team has a wealth of experience and can assist customers in experimental design, data interpretation and other aspects of the provision of a full range of support to ensure the scientific quality of the research and the success of the study.
Conclusion
By providing advanced genetically engineered homology models, InnoModels Biotechnology opens the door for scientists to explore the mysteries of biology in depth. Its efficient and professional services provide researchers in the field of life sciences with a powerful tool that promotes the study of disease mechanisms, drug development and the advancement of basic science. With the continuous development of science and technology, InnoModels Biotechnology will continue to lead the innovation in the field of homology modeling and contribute more to the global life science research.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd